0001213900-20-016308.txt : 20200630 0001213900-20-016308.hdr.sgml : 20200630 20200630161113 ACCESSION NUMBER: 0001213900-20-016308 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200626 FILED AS OF DATE: 20200630 DATE AS OF CHANGE: 20200630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOFFMAN ROBERT CENTRAL INDEX KEY: 0001166288 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37823 FILM NUMBER: 201002447 MAIL ADDRESS: STREET 1: ARENA PHARMACEUTICALS INC STREET 2: 6166 NANCY RIDER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DelMar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001498382 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 990360497 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 12707 HIGH BLUFF DR., SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 350-4364 MAIL ADDRESS: STREET 1: 12707 HIGH BLUFF DR., SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Berry Only Inc. DATE OF NAME CHANGE: 20100805 4 1 ownership.xml X0306 4 2020-06-26 0 0001498382 DelMar Pharmaceuticals, Inc. DMPI 0001166288 HOFFMAN ROBERT 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 1 0 0 0 Options (Right to Buy) 0.61 2020-06-26 4 A 0 39567 0 A 2029-09-05 Common Stock 39567 75000 D On September 5, 2019, the reporting person received options to purchase 39,567 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020. The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019. /s/ Anthony Scott Praill, attorney-in-fact for Robert Hoffman 2020-06-30